Back to Search Start Over

Content Validity of the Modified Functional Scale for the Assessment and Rating of Ataxia (f-SARA) Instrument in Spinocerebellar Ataxia.

Authors :
Potashman, Michele
Rudell, Katja
Pavisic, Ivanna
Suminski, Naomi
Doma, Rinchen
Heinrich, Maggie
Abetz-Webb, Linda
Beiner, Melissa Wolfe
Kuo, Sheng-Han
Rosenthal, Liana S.
Zesiwicz, Theresa
Fife, Terry D.
van de Warrenburg, Bart P.
Ristori, Giovanni
Synofzik, Matthis
Perlman, Susan
Schmahmann, Jeremy D.
L'Italien, Gilbert
Source :
Cerebellum; Oct2024, Vol. 23 Issue 5, p2012-2027, 16p
Publication Year :
2024

Abstract

The functional Scale for the Assessment and Rating of Ataxia (f-SARA) assesses Gait, Stance, Sitting, and Speech. It was developed as a potentially clinically meaningful measure of spinocerebellar ataxia (SCA) progression for clinical trial use. Here, we evaluated content validity of the f-SARA. Qualitative interviews were conducted among individuals with SCA1 (n = 1) and SCA3 (n = 6) and healthcare professionals (HCPs) with SCA expertise (USA, n = 5; Europe, n = 3). Interviews evaluated symptoms and signs of SCA and relevance of f-SARA concepts for SCA. HCP cognitive debriefing was conducted. Interviews were recorded, transcribed, coded, and analyzed by ATLAS.TI software. Individuals with SCA1 and 3 reported 85 symptoms, signs, and impacts of SCA. All indicated difficulties with walking, stance, balance, speech, fatigue, emotions, and work. All individuals with SCA1 and 3 considered Gait, Stance, and Speech relevant f-SARA concepts; 3 considered Sitting relevant (42.9%). All HCPs considered Gait and Speech relevant; 5 (62.5%) indicated Stance was relevant. Sitting was considered a late-stage disease indicator. Most HCPs suggested inclusion of appendicular items would enhance clinical relevance. Cognitive debriefing supported clarity and comprehension of f-SARA. Maintaining current abilities on f-SARA items for 1 year was considered meaningful for most individuals with SCA1 and 3. All HCPs considered meaningful changes as stability in f-SARA score over 1–2 years, 1–2-point change in total f-SARA score, and deviation from natural history. These results support content validity of f-SARA for assessing SCA disease progression in clinical trials. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14734222
Volume :
23
Issue :
5
Database :
Complementary Index
Journal :
Cerebellum
Publication Type :
Academic Journal
Accession number :
180372202
Full Text :
https://doi.org/10.1007/s12311-024-01700-2